Bharati R Dhruva

Array ( [id] => 13107265 [patent_doc_number] => 10072266 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-09-11 [patent_title] => STAT5 inhibitors and use thereof [patent_app_type] => utility [patent_app_number] => 15/127535 [patent_app_country] => US [patent_app_date] => 2015-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 10877 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15127535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11528878 [patent_doc_number] => 20170088856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-30 [patent_title] => 'Genome Editing without Nucleases' [patent_app_type] => utility [patent_app_number] => 15/126860 [patent_app_country] => US [patent_app_date] => 2015-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 20723 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15126860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11512919 [patent_doc_number] => 20170079992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-23 [patent_title] => 'METAKARYOCIDAL TREATMENTS' [patent_app_type] => utility [patent_app_number] => 15/126369 [patent_app_country] => US [patent_app_date] => 2015-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11060 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15126369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12509862 [patent_doc_number] => 10000741 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-19 [patent_title] => Compositions and methods for enhanced gene expression in cone cells [patent_app_type] => utility [patent_app_number] => 14/660657 [patent_app_country] => US [patent_app_date] => 2015-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 28 [patent_no_of_words] => 29118 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14660657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11827640 [patent_doc_number] => 09724369 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-08 [patent_title] => 'Methods of maintaining fat volume' [patent_app_type] => utility [patent_app_number] => 14/657825 [patent_app_country] => US [patent_app_date] => 2015-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 18 [patent_no_of_words] => 6478 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14657825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10367356 [patent_doc_number] => 20150252358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-10 [patent_title] => 'CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING LEBER\'S CONGENITAL AMAUROSIS 10 (LCA10)' [patent_app_type] => utility [patent_app_number] => 14/644181 [patent_app_country] => US [patent_app_date] => 2015-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 74 [patent_figures_cnt] => 74 [patent_no_of_words] => 107032 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14644181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13763905 [patent_doc_number] => 10174287 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-08 [patent_title] => Composition for inducing direct transdifferentiation of somatic cell into vascular progenitor cell, and use thereof [patent_app_type] => utility [patent_app_number] => 15/120171 [patent_app_country] => US [patent_app_date] => 2015-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 4292 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15120171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11859199 [patent_doc_number] => 09738873 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-22 [patent_title] => 'Activation of innate immunity for enhanced nuclear reprogramming of somatic cells with mRNA' [patent_app_type] => utility [patent_app_number] => 14/615955 [patent_app_country] => US [patent_app_date] => 2015-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 5 [patent_no_of_words] => 10590 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14615955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12217591 [patent_doc_number] => 20180055950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-03-01 [patent_title] => 'NEURONAL SPECIFIC TARGETING OF CAVEOLIN EXPRESSION TO RESTORE SYNAPTIC SIGNALING AND IMPROVE COGNITIVE FUNCTION IN THE NEURODEGENERATIVE BRAIN AND MOTOR FUNCTION IN SPINAL CORD' [patent_app_type] => utility [patent_app_number] => 14/608153 [patent_app_country] => US [patent_app_date] => 2015-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 24256 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 70 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14608153 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10311685 [patent_doc_number] => 20150196687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-16 [patent_title] => 'Compositions and Uses to Govern Cancer Cell Growth' [patent_app_type] => utility [patent_app_number] => 14/592395 [patent_app_country] => US [patent_app_date] => 2015-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 23885 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14592395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11535971 [patent_doc_number] => 09610364 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2017-04-04 [patent_title] => 'Method for the treatment of malignancies' [patent_app_type] => utility [patent_app_number] => 14/589463 [patent_app_country] => US [patent_app_date] => 2015-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 33 [patent_no_of_words] => 12481 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14589463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11436408 [patent_doc_number] => 20170037430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-09 [patent_title] => 'Lyophilized Lentiviral Vector Particles, Compositions and Methods' [patent_app_type] => utility [patent_app_number] => 15/106862 [patent_app_country] => US [patent_app_date] => 2014-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14230 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15106862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13856765 [patent_doc_number] => 10190094 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-29 [patent_title] => Methods and compositions related to induced sensory neurons [patent_app_type] => utility [patent_app_number] => 15/106460 [patent_app_country] => US [patent_app_date] => 2014-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16717 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15106460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11114935 [patent_doc_number] => 20160311907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-27 [patent_title] => 'REGULATABLE CHIMERIC ANTIGEN RECEPTOR' [patent_app_type] => utility [patent_app_number] => 15/105074 [patent_app_country] => US [patent_app_date] => 2014-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 134931 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 38 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10326018 [patent_doc_number] => 20150211021 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-30 [patent_title] => 'MEMBRANE-PENETRATING PEPTIDES TO ENHANCE TRANSFECTION AND COMPOSITIONS AND METHODS FOR USING SAME' [patent_app_type] => utility [patent_app_number] => 14/569583 [patent_app_country] => US [patent_app_date] => 2014-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 32536 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14569583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11901979 [patent_doc_number] => 09771403 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-26 [patent_title] => 'Methods and compositions for treating hemophilia' [patent_app_type] => utility [patent_app_number] => 14/564722 [patent_app_country] => US [patent_app_date] => 2014-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 24042 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14564722 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11298034 [patent_doc_number] => 09506031 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-29 [patent_title] => 'Methods and materials for increasing potency of cells' [patent_app_type] => utility [patent_app_number] => 14/563459 [patent_app_country] => US [patent_app_date] => 2014-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 8363 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14563459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11113453 [patent_doc_number] => 20160310425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-27 [patent_title] => 'LIPOSOMAL PARTICLES, METHODS OF MAKING SAME AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/101523 [patent_app_country] => US [patent_app_date] => 2014-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 16736 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15101523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11224511 [patent_doc_number] => 09452221 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-09-27 [patent_title] => 'Poly(acrylate) polymers for in vivo nucleic acid delivery' [patent_app_type] => utility [patent_app_number] => 14/552664 [patent_app_country] => US [patent_app_date] => 2014-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 24158 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14552664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11090707 [patent_doc_number] => 20160287675 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-06 [patent_title] => 'TREATMENT FOR CANCER' [patent_app_type] => utility [patent_app_number] => 15/038345 [patent_app_country] => US [patent_app_date] => 2014-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17507 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 47 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15038345 [rel_patent_id] =>[rel_patent_doc_number] =>)